Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Flat Funding Is Not Sufficient: Urge Congress to Pass a Full Funding Bill and Support Cancer Research

Oncology Practice Insider

Congress passed another continuing resolution (CR) on November 21 – the second CR since the start of the fiscal year (FY), which was October 1. The CR provides flat funding for government agencies through December 20 to avoid a government shutdown and gives Congress more time to come to an agreement on a final FY 2020 appropriations package.

Short-term spending bills make it difficult for the National Institutes of Health (NIH), as well as the institutions and scientists it supports, to effectively plan for research projects.  

ASCO joined with One Voice Against Cancer (OVAC) in asking Congress to pass a full FY 2020 funding bill with the highest possible funding increase for the NIH, along with a proportional increase for the National Cancer Institute (NCI). We are thankful to appropriators and Congressional leadership that NIH’s budget has increased by 29 percent over the last four years, but we have not caught up from years of stagnant funding and NCI’s budget has not kept pace. Flat funding and long-term CR’s create inefficiencies and uncertainty for scientists across the country.

Tell Congress to pass a full FY 2020 funding bill that invests in cancer research.